Integral Health Asset Management, LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1773206 New York, NY

Position in DNLI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,572,000

-$4,974,500 QoQ

Shares Held

100,000

-69.2% QoQ

Ownership

0.063%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#88

of 290 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Integral Health Asset Management, LLC holds $1,502,601,600 across 54 Biotechnology names. DNLI ranks #51 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	1,500,000	$280,920,000
2	INSM	INSMED Inc	1,600,000	$170,592,000
3	CYTK	Cytokinetics Inc	1,600,000	$136,304,000
4	EWTX	Edgewise Therapeutics, Inc.	2,000,000	$81,260,000
5	VERA	Vera Therapeutics, Inc.	1,750,000	$75,092,500
6	AXSM	Axsome Therapeutics, Inc.	300,000	$73,431,000
7	ROIV	Roivant Sciences Ltd.	2,000,000	$70,780,000
8	RYTM	Rhythm Pharmaceuticals, Inc.	550,000	$61,066,500

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,572,000	100,000	-69.2%	Shares	Sole	2026-08-14
2024-06-30	$7,546,500	325,000	+182.6%	Shares	Sole	2024-08-14
2022-09-30	$3,529,350	115,000	+342.3%	Shares	Sole	2022-11-14
2022-03-31	$836,420	26,000	-74.0%	Shares	Sole	2022-05-12
2021-12-31	$4,460,000	100,000	+33.3%	Shares	Sole	2022-02-02
2021-09-30	$3,783,750	75,000	-22.7%	Shares	Sole	2021-11-12
2021-03-31	$5,538,700	97,000	+68.7%	Shares	Sole	2021-05-10
2020-12-31	$4,816,200	57,500	-65.2%	Shares	Sole	2021-02-16
2020-09-30	$5,911,950	165,000	+26.9%	Shares	Sole	2020-11-16
2020-06-30	$3,143,400	130,000	+44.4%	Shares	Sole	2020-08-14
2020-03-31	$1,575,900	90,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.